Sensitivity of multiple myeloma cells to mTOR inhibitors

Ratneshwar Lal

Amyloid ion channels to design therapeutics for neurodegenerative diseases

Multiple myeloma and immunoproliferative diseases

Pathology

Richard A Flavell

Understanding Hemotopoietic Neoplasias using Humanized Mice

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Monica M Bertagnolli

Alliance for Clinical Trials in Oncology Operations Center

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Stephanie J Lee

Improving Outcomes Assessment in Chronic Graft versus Host Disease

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Ralph D Sanderson

Novel Heparanase Inhibitors for Cancer Therapy

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Nikhil C Munshi

Genomic Analysis to Gain Insights into Novel and Clinically Relevant Mol

Multiple myeloma and immunoproliferative diseases

Pathology Hematology and hematologic malignancies

Kenneth C. Anderson

SPORE in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases